WAVE Life Sciences Ltd Business Update Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Wave Life Sciences business update. (Operator Instructions)
I would now like to turn the call over to your host, (inaudible), you may begin.
Thank you, operator. Good morning, and thank you for joining us today. I will be covering for Kate Rausch, while she's on maternity leave. This morning, Wade issued a news release announcing a strategic collaboration between Wave and GSK, focused on discovery and development of oligonucleotide therapeutics. The slide presentation to accompany this webcast is available at the Investors section of our website at www.Wavelifesciences.com. A replay of this call will also be available on the website following the call.
Joining me on the call today with prepared remarks is Dr. Paul Bolno, Wave's President and Chief Executive Officer; Chris Francis, Waveâs SVP of Corporate Development, is also on the call and will be available for questions.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |